- The trend backdrop is active with a 9-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is constructive, supporting the smart-money activity read.
HLUN-B
CPH
Week ended 07 Aug 2026
Weekly Investor Report
H. Lundbeck A/S · Healthcare · Drug Manufacturers - Specialty & Generic
Latest close
41.58 DKK
0.2%
latest week
Weekly setup
Mixed setup
The weekly trend is active. Price is 1.0% above the Trend Line and sits at 62.9% of its 52-week range. The latest completed week returned 0.2%, after a -2.1% four-week move. The latest news-sentiment score is 54/100.
Setup score
45
out of 100
Latest Close
41.58 DKK
7 Aug 2026
1W Return
0.2%
latest completed week
4W Return
-2.1%
short-term follow-through
12W Return
0.5%
quarterly tape
Trend Breadth
59.6%
31 of 52 weeks active
Volume Ratio
1.0x
vs 13-week average
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
0.2%
Latest completed week; four-week move -2.1%.
Indicator stack
64/2
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
54/100
10 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 1.0% above the Trend Line and sits at 62.9% of its 52-week range. The latest completed week returned 0.2%, after a -2.1% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.0x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.6112-week average 0.61
12-week confirmation
Trend active9/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure9/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership5/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.61Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -2.1% over four weeks, 0.5% over 12 weeks, and 23.0% over one year. The current trend has remained active for 9 consecutive weeks.
Performance by holding period
Active trend streak9 weeks
Active weeks in one year31
Trend breadth59.6%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.43Latest activity-pressure read.
Pressure change-500.0%Four-week change in activity pressure.
Leadership-5.16Latest relative-leadership reading.
RS change-49.9%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment54/100
Weighted news tone is neutral across 10 relevant articles.
2 positive · 8 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-10.3%Distance below the 52-week high.
13-week volatility2.6%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher15 of 2611 weeks finished lower.
Best week+5.5%Week of 3 Apr.
Worst week-5.0%Week of 19 Jun.
Latest week+0.2%Week of 7 Aug.
Shape of recent returns
Strong gains4
Modest gains11
Flat weeks0
Modest losses9
Sharp losses2
Recent vol2.6%13-week weekly-return volatility.
Base vol3.7%52-week weekly-return volatility.
Up/down split30/21Count of positive and negative weeks in the 52-week window.
Average skew2.8% / -2.9%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorDK Healthcare
4-week rank15 / 21
Group average4.0%
Trend breadth28.6%
Trend28.6%active weekly trend signals
MD66.7%positive activity pressure
RS14.3%positive relative leadership
Four-week leaders
IndustryDK Drug Manufacturers - Specialty & Generic
4-week rank2 / 3
Group average-3.7%
Trend breadth66.7%
Trend66.7%active weekly trend signals
MD0.0%positive activity pressure
RS0.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape44/100
Trend, activity pressure, participation, and risk combine to a 44/100 tape read.
Indicator analysis62/100Latest 12-week confirmation: trend 9/12, activity pressure 9/12, relative leadership 5/12.
Activity pressure 0.61; No reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment54/100Weighted news tone is neutral across 10 relevant articles.
Lundbeck Receives FDA Fast Track Designation for Lu AH69593, Investigational Orexin 2 Receptor Agonist for Narcolepsy Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 41.58 DKK | 0.2% | 41.18 DKK | 37.66 DKK | -0.43 | -5.16 | 2.2M | On |
| 31 Jul 2026 | 41.50 DKK | -1.5% | 41.25 DKK | 37.61 DKK | -0.31 | -4.91 | 2.4M | On |
| 24 Jul 2026 | 42.12 DKK | -1.7% | 41.25 DKK | 37.55 DKK | -0.11 | -2.75 | 1.7M | On |
| 17 Jul 2026 | 42.86 DKK | 0.9% | 41.24 DKK | 37.47 DKK | 0.04 | -4.42 | 1.9M | On |
| 10 Jul 2026 | 42.48 DKK | -1.5% | 41.21 DKK | 37.40 DKK | 0.11 | -3.44 | 2.2M | On |
| 3 Jul 2026 | 43.12 DKK | 2.7% | 41.19 DKK | 37.31 DKK | 0.29 | -3.00 | 533.2K | On |
| 26 Jun 2026 | 42.00 DKK | 1.2% | 41.20 DKK | 37.22 DKK | 0.54 | -0.30 | 422.4K | On |
| 19 Jun 2026 | 41.52 DKK | -5.0% | 41.24 DKK | 37.15 DKK | 0.79 | 2.04 | 863.1K | On |
| 12 Jun 2026 | 43.70 DKK | -2.5% | 41.28 DKK | 37.09 DKK | 0.98 | 6.03 | 478.8K | On |
| 5 Jun 2026 | 44.80 DKK | 3.2% | 41.30 DKK | 37.03 DKK | 1.01 | 9.94 | 3.9M | Off |
| 29 May 2026 | 43.42 DKK | 3.8% | 41.27 DKK | 36.96 DKK | 0.87 | 5.28 | 4.9M | Off |
| 22 May 2026 | 41.82 DKK | 1.1% | 41.35 DKK | 36.90 DKK | 0.67 | 1.71 | 4.5M | Off |
| 15 May 2026 | 41.38 DKK | -3.9% | 41.45 DKK | 36.85 DKK | 0.57 | 1.93 | 3.4M | Off |
| 8 May 2026 | 43.06 DKK | 1.6% | 41.54 DKK | 36.81 DKK | 0.45 | 7.78 | 2.7M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.